2026 Diabetic Lower Extremity Symposium

An In-Person Conference  |  November 12-13, 2026
Joseph B. Martin Conference Center, Boston, MA

The Rongxiang Xu, MD, Center for Regenerative Therapeutics at Beth Israel Deaconess Medical Center and the Wyss Institute at Harvard University present:

The Diabetic Lower Extremity Symposium
From  Innovation to Therapy

Joseph B. Martin Conference Center

77 Avenue Louis Pasteur, Boston, MA 02115

November 12-13, 2026

Day
Hour
Minute
Second
4464d118f548432fb0c3d33d418e2208

This CME meeting will focus on the management of diabetic lower extremity and other chronic wounds. The meeting will include top experts from all over the world and will facilitate interaction between small and big pharma and academicians.

781e5f4c27a34da18ce7da0a6c74035f

What is this meeting about? 

Diabetic foot problems significantly impair the quality of life of diabetic patients. Each year in the United States, these complications lead to more than 750,000 new diabetic foot ulcers and 70,000 lower extremity amputations. This extraordinary symposium will promote better understanding of the unmet management needs of Diabetic Lower Extremity (DLE) complications and the new therapeutic approaches that are currently under development.

Accreditation

*Please note that our 2024 accreditation is displayed for reference.  Please check back for 2026 updates.

Joint Accreditation Statement

In support of improving patient care, this activity has been planned and implemented by Amedco LLC and Well Assembled Meetings.  Amedco LLC is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.  Amedco Joint Accreditation #4008163.

Physicians

Amedco LLC designates this live activity for a maximum of 13.25 AMA PRA Category 1 CreditsTM. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Nurses

Amedco LLC designates this activity for a maximum of 13.25 ANCC contact hours.

Physician Assistants

The National Commission on Certification of Physician Assistants (NCCPA) states that AMA PRA Category 1 Credits™ are acceptable for continuing medical education requirements for recertification for PAs. 13.25 hours.

Nurse Practitioners

The American Association of Nurse Practitioners (AANP) recognizes the Accreditation Council for Continuing Medical Education (ACCME) and the American Nurses Credentialing Center (ANCC) as approved accreditors and allow reciprocity for AANPCP continuing education credit. 13.25 Hours

 

Main objectives:

  • Provide an overview of current and unmet management of DLE complications caused by reduced blood supply and/or neuropathic damage
  • Discuss new developments in basic, translational and biomaterial research that impact DLE management
  • Explore new therapeutic approaches, from early pre-clinical to late clinical stage of development through presentations from leaders in academia and in the biotechnology industry
  • Identify possible areas of collaboration between academia and industry

Who should attend this symposium?

  • Physicians involved in DLE management (general, vascular and plastic surgeons, podiatrists, diabetologists, ID specialists, neurologists, wound care specialists)
  • Scientists and engineers involved in fundamental or translational biomaterial research
  • R&D personnel from small and large pharmaceutical and biotechnology companies involved in the development of new therapeutic approaches for DLE
7ad841f193b7464ca1cce8d4ed2f0a33
  • Physician...............................$465
  • PhD/Professor........................$295
  • RN/Staff...................................$95
  • Fellow/Resident/Student..........$65
Contact Us
Register Online
Exhibit with Us

Call for Abstracts

The symposium organizers welcome abstracts for poster submissions from  academic labs, clinical units and all levels of industry. Posters that  address the biology, management and treatment of diabetic lower  extremity complications, including new potential therapeutic strategies  will be considered.  The best three posters will be presented as oral  presentations. Prizes for the best posters will be offered.

 

Submit Your Abstract

Thank you to our Prior Exhibitors

*Please note that our 2024 Exhibitors are displayed for reference.  Please check back for 2026 updates.